Menahem Samuel, Lefkovits Jeffrey
Melbourne Children's Cardiology/Adult Congenital Heart, Melbourne, VIC 3161, Australia.
Department of Paediatrics, Monash University, Melbourne, VIC 3800, Australia.
Children (Basel). 2021 Oct 29;8(11):981. doi: 10.3390/children8110981.
Considerable advances have occurred in the understanding of Kawasaki disease, with a substantial drop in morbidity and mortality following the infusion of gamma globulin during the acute phase. Nevertheless, major complications may still occur. A 27-year-old male presented as an infant of 11 weeks when he was diagnosed as having Kawasaki disease. He was appropriately treated with aspirin and a gamma globulin infusion following his diagnosis 5 days after the onset of his illness. Despite that, he went on to develop coronary aneurysms. He represented a few weeks later with a history of inconsolable crying associated with pallor, suggestive of ischaemic chest pain. A repeat echocardiogram revealed infarction of the apex of the left ventricle with localised thrombus formation. There were persistent aneurysms within both coronary artery systems. A further infusion of gamma globulin was given. In view of the thrombus formation, he was started on warfarin. The thrombus gradually resolved with the development of a clearly defined left ventricular apical aneurysm. He has remained on warfarin, aiming for an international normalised ratio (INR) level of 2 to 2.5. He developed mild left ventricular dysfunction during late childhood, which improved following the commencement of an angiotensin-converting enzyme (ACE) inhibitor. Despite his ventricular aneurysm, there has been no documented evidence of ventricular tachycardia over the years. Repeated testing initially by nuclear perfusion scans and then by stress echocardiograms failed to show any inducible ischaemia apart from the apical ventricular aneurysm. A recent computed tomography (CT) coronary angiogram revealed an ectatic origin of the left main and the right coronary arteries with mild calcification involving the mid-portion of the latter and slight calcification of the former. His raised cholesterol level has responded well to a statin. Despite the persistence of the ventricular aneurysm, he continues to be managed conservatively, as he has remained well. The question arises as to what the long-term implications are of his left ventricle apical aneurysm. Should it be excised? Is he at risk for ventricular tachycardia and sudden death? In addition, although the coronary aneurysms have resolved, the CT coronary angiogram shows calcium plaques in both coronary arteries at the site of the earlier aneurysms. This finding raises the question as to whether all children who develop coronary artery aneurysms following Kawasaki disease should have a CT coronary angiogram performed in adulthood.
在川崎病的认识方面已取得了相当大的进展,急性期输注丙种球蛋白后发病率和死亡率大幅下降。然而,主要并发症仍可能发生。一名27岁男性在11周大时被诊断为川崎病。发病5天后确诊,随后接受了阿司匹林和丙种球蛋白输注的适当治疗。尽管如此,他还是发展为冠状动脉瘤。几周后他再次就诊,有难以安抚的哭闹史,伴有面色苍白,提示缺血性胸痛。复查超声心动图显示左心室心尖梗死并伴有局部血栓形成。两个冠状动脉系统内均有持续性动脉瘤。又进行了一次丙种球蛋白输注。鉴于血栓形成,开始给他使用华法林。随着明确的左心室心尖动脉瘤的形成,血栓逐渐溶解。他一直服用华法林,目标国际标准化比值(INR)水平为2至2.5。他在儿童晚期出现轻度左心室功能障碍,在开始使用血管紧张素转换酶(ACE)抑制剂后有所改善。尽管有室壁瘤,但多年来没有记录到室性心动过速的证据。最初通过核灌注扫描,然后通过负荷超声心动图反复检查,除心尖室壁瘤外,未显示任何可诱发的缺血。最近的计算机断层扫描(CT)冠状动脉造影显示左主干和右冠状动脉起源扩张,后者中段有轻度钙化,前者有轻微钙化。他升高的胆固醇水平对他汀类药物反应良好。尽管室壁瘤持续存在,但由于他一直状况良好,仍继续采取保守治疗。关于他左心室心尖动脉瘤的长期影响是什么,这一问题随之而来。是否应该切除?他有室性心动过速和猝死的风险吗?此外,尽管冠状动脉瘤已消退,但CT冠状动脉造影显示早期动脉瘤部位的两条冠状动脉均有钙斑。这一发现引发了一个问题,即所有川崎病后发生冠状动脉瘤的儿童在成年后是否都应进行CT冠状动脉造影。